There is two documents in here one is the information that you will be using to answer the question in the other document is the questions to answers You will be using two companies i need you to answer all the question for the following company Pfizer and answer the same question for the company Johnson & Johnson!

Any question that you have about this let me know before doing it..!

1. Select two companies from Table 1A Pfizer Johnson & Johnson 2. Find for each company the following data as appeared in the last year of publication: PFIZER Pfizer Inc is a research-based biopharmaceutical company. The Company's portfolio includes medicines, vaccines and medical devices, as well as many of the consumer healthcare products. Industry classification NAICS - Pharmaceutical Preparation Manufacturing (325412) SIC - Pharmaceutical and Medicine Industry (3741) / Pharmaceutical Preparations (2834) ISIC - Manufacture of Pharmaceuticals, Medicinal Chemical and Botanical Products (2100) Type of industry Drug Manufacturers - Major The main subsidiaries and their locations (host countries). Agouron Pharmaceuticals - 10777 Science Center Drive San Diego, CA 92121-1111 United States G.D. Searle - New York City, United States Greenstone - GREENSTONE LLC 100 Route 206 North Peapack, NJ 07977 Hospira - Lake Forest, Illinois, United States InnoPharma - Piscataway Township, NJ Parke-Davis - Parke-davis Detroit, Michigan, United States Pfizer UK - Pfizer uk Tadworth, Surrey, United Kingdom The number of overseas employees compared to total employees. As of December 31, 2015, there were approximately 97,900 people in our operations throughout the world. Description of companies' common shares, preferred shares, bonds, options and derivatives. Total value of Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2015649; 2014717 having $26 million and Common stock, $0.05 par value; 12,000 shares authorized; issued: 20159,178; 20149,110 having $459 million . Additional Paid In capital was $459 million in 2015.Total value of Long term debt amounted to $28,818 million. As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. Total value of unrealized holding gain arising during the period amounted to $204 million and reclassification to earnings amounted to $368 million resulting in a total net change of $165 million. Common stock or equity has been traded at quoted market prices. The security markets related to companies securities. Trading debt securitiesobservable market interest rates Overseas sales and local sales. Total revenue from sales was $48,851 million. Out of which $13,954 revenue belonged to GIP segment $12,803 value of revenue belonged to VOC segment, $21,857 million of revenue belonged to GEP segment and revenues from other business activities were $506 million resulting in total revenue of $48,851 million. Johnson & Johnson Industry classification Medical equipment Type of industry Pharmaceutical The main subsidiaries and their locations (host countries). McNeil Consumer Healthcare - Fort Washington, Pennsylvania, United States Vistakon - Jacksonville, FL EE. UU. Neutrogena - Los Angeles, United States DePuy - Warsaw, IN united states The number of overseas employees compared to total employees. Number of total employees employed are 127,100. Johnson & Johnson and its subsidiaries (the "Company") have approximately 127,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field Description of companies' common shares, preferred shares, bonds, options and derivatives. Company had common stock of $1 par value per share. It has 4,320,000,000 Authorized shares and number of shares issued 3,119,843,000 shares of $3,120 million. Company also has preferred shares of no par value of authorized and unissued shares of 2,000,000.Total value of long term debt was $12,857 million which consists of debentures and long term notes payable. As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. Total value of unrealized loss arising during the period amounted to $115 million and reclassification to earnings amounted to $62 million resulting in a total net change of $177 million. The security markets related to companies securities. Common stocks are valued at the closing price reported on the major market on which the individual securities are traded. Substantially all common stock is classified within Level 1 of the valuation hierarchy. Overseas sales and local sales. Total value of sales to U.S. customers amounted to $35,687 million and to International customers amounted to $34,387 million resulting in a total sales of $70,074 million in 2015 3. Construct a table to summarize the data as follows: Variable (year 2015) The main products Company 1 Pfizer Accupril Lipitor Viagra Company 2 Johnson & Johnson Baby Care Home country Estados Unidos, Inglaterra Location of subsidiaries Agouron Pharmaceuticals - 10777 Science Center Drive San Diego, CA 92121-1111 United States Estados Unidos, Espaa, Francia, Blgica, Suiza, china, India, Reino Unido McNeil Consumer Healthcare Fort Washington, Pennsylvania, United States G.D. Searle - New York City, United Vistakon - Jacksonville, FL EE. States UU. Greenstone- GREENSTONE LLC 100 Route 206 North Peapack, NJ 07977 Neutrogena - Los Angeles, United States DePuy - Warsaw, IN united states Hospira - Lake Forest, Illinois, United States InnoPharma - Piscataway Township, NJ Parke-Davis - Parke-davis Detroit, Michigan, United States Pfizer UK - Pfizer uk Tadworth, Surrey, United Kingdom Total employment Overseas employment Local employment Total common shares Total preferred shares Total bonds Total long term debt Where the shares are traded 97,900 $459 million $26 million $28,818 million As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. Total sales Local sales Overseas sales (profits) $48,851 million $69 million 127,100 2,000,000 $12,857 million As required by U.S. GAAP, all derivative instruments are recorded on the balance sheet at fair value. $70.074 million 50.9 million Research 2 Investment As an investor you need to calculate the main ratios. o Internal liquidity ratios: Current ratio. o Operating performance: Operating efficiency ratios: total asset turnover. o Operating profitability ratios: Gross profit margin, Operating profit margin, Net profit margin, Return on total capital, (ROE). o Risk analysis Business risk: Type of industry. The variability of the firm's operating income over time (sales variability, and operating leverage). o Financial risk Uncertainty of acquiring debt, the acceptable level of financial risk for a firm depends on its business risk. Debt ratios: debt-equity ratio, long-term debt/total capital ratio, total debt ratio. Interest coverage Cash flow coverage ratio, cash flow-long term debt ratio, cash flow/total debt ratio. o External liquidity risk (determinants of market liquidity) Comparing the market data with the companies' data. As an investor, you have to decide the possibility to invest in these companies and explaining the reasoning of your decision. o Summary Of the main and relevant issues found from the data. o Investment decision Considering the data, investment theories do you recommend to invest in these companies individually or as a portfolio. o Comparison between theory and practices in investment. The most relevant aspects of your project. Identify the most issue that you considered important in considering to invest in the sample companies. Identify a practice or a theory to support your discussion